161 related articles for article (PubMed ID: 12558609)
1. Preserved bronchial dilatation after salbutamol does not guarantee protection against bronchial hyperresponsiveness.
Sjöswärd KN; Josefsson M; Ahlner J; Schmekel B
Clin Physiol Funct Imaging; 2003 Jan; 23(1):14-20. PubMed ID: 12558609
[TBL] [Abstract][Full Text] [Related]
2. Single-isomer R-salbutamol is not superior to racemate regarding protection for bronchial hyperresponsiveness.
Sjöswärd KN; Hmani M; Davidsson A; Söderkvist P; Schmekel B
Respir Med; 2004 Oct; 98(10):990-9. PubMed ID: 15481276
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of levosalbutamol: what are the clinical implications?
Boulton DW; Fawcett JP
Clin Pharmacokinet; 2001 Jan; 40(1):23-40. PubMed ID: 11236808
[TBL] [Abstract][Full Text] [Related]
4. Airway responsiveness to beta-adrenergic agonist (salbutamol) in asthma.
Boskabady MH; Saadatinejad M
J Asthma; 2003 Dec; 40(8):917-25. PubMed ID: 14736092
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi.
Matera MG; Calzetta L; Rogliani P; Bardaro F; Page CP; Cazzola M
Pulm Pharmacol Ther; 2011 Apr; 24(2):221-6. PubMed ID: 21195788
[TBL] [Abstract][Full Text] [Related]
6. Levosalbutamol in the treatment of asthma.
Milgrom H
Expert Opin Pharmacother; 2006 Aug; 7(12):1659-68. PubMed ID: 16872269
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.
Lipworth BJ; Clark DJ; Koch P; Arbeeny C
Thorax; 1997 Oct; 52(10):849-52. PubMed ID: 9404370
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
[TBL] [Abstract][Full Text] [Related]
9. Tolerance to the bronchoprotective effect of beta2-agonists: comparison of the enantiomers of salbutamol with racemic salbutamol and placebo.
Cockcroft DW; Davis BE; Swystun VA; Marciniuk DD
J Allergy Clin Immunol; 1999 Jun; 103(6):1049-53. PubMed ID: 10359885
[TBL] [Abstract][Full Text] [Related]
10. Hyperresponsiveness of the airways following exposure of guinea-pigs to racemic mixtures and distomers of beta 2-selective sympathomimetics.
Mazzoni L; Naef R; Chapman ID; Morley J
Pulm Pharmacol; 1994 Dec; 7(6):367-76. PubMed ID: 7549224
[TBL] [Abstract][Full Text] [Related]
11. (R,S)-salbutamol plasma concentrations in severe asthma.
Jacobson GA; Chong FV; Wood-Baker R
J Clin Pharm Ther; 2003 Jun; 28(3):235-8. PubMed ID: 12795782
[TBL] [Abstract][Full Text] [Related]
12. Discrimination of prohibited oral use of salbutamol from authorized inhaled asthma treatment.
Bergés R; Segura J; Ventura R; Fitch KD; Morton AR; Farré M; Mas M; de La Torre X
Clin Chem; 2000 Sep; 46(9):1365-75. PubMed ID: 10973867
[TBL] [Abstract][Full Text] [Related]
13. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
van der Woude HJ; Winter TH; Aalbers R
Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
[TBL] [Abstract][Full Text] [Related]
14. Levalbuterol and racemic albuterol: are there therapeutic differences?
Ahrens R; Weinberger M
J Allergy Clin Immunol; 2001 Nov; 108(5):681-4. PubMed ID: 11692088
[No Abstract] [Full Text] [Related]
15. Beta2-agonist eutomers: a rational option for the treatment of asthma?
Boulton DW; Fawcett JP
Am J Respir Med; 2002; 1(5):305-11. PubMed ID: 14720033
[TBL] [Abstract][Full Text] [Related]
16. Bronchoprotective and bronchodilator effects of single doses of (S)-salbutamol, (R)-salbutamol and racemic salbutamol in patients with bronchial asthma.
Ramsay CM; Cowan J; Flannery E; McLachlan C; Taylor DR
Eur J Clin Pharmacol; 1999 Jul; 55(5):353-9. PubMed ID: 10456484
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with levalbuterol.
Nelson HS
J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 2):S77-84. PubMed ID: 10452792
[TBL] [Abstract][Full Text] [Related]
18. Regular inhaled salbutamol : effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection.
Jokic R; Swystun VA; Davis BE; Cockcroft DW
Chest; 2001 Feb; 119(2):370-5. PubMed ID: 11171711
[TBL] [Abstract][Full Text] [Related]
19. Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine.
Cockcroft DW; Swystun VA
Thorax; 1997 Oct; 52(10):845-8. PubMed ID: 9404369
[TBL] [Abstract][Full Text] [Related]
20. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature.
Bisgaard H
Pediatr Pulmonol; 2000 Mar; 29(3):221-34. PubMed ID: 10686044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
